Cancer Gene Therapy IndustryThe global cancer gene therapy industry is projected to increase at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2032, with a projected value of US$ 2 billion in 2022. According to Future Market Insights (FMI), the oncolytic virotherapy category held 49.3% of the global canc.
From 2022 to 2032, the global cancer gene therapy market is anticipated to expand at a 10.1% compound annual growth rate (CAGR) and reach US$ 2 billion in 2022. The oncolytic virotherapy segment held 49.3% of the global cancer gene therapy market in 2021, according to Future Market Insights (FMI). This market is pro.
/PRNewswire/ - FluidAI Medical (FluidAI), a pioneer in leveraging artificial intelligence (AI) for postoperative patient monitoring, today announced that it.